Ganga Pharmaceuticals Limited
BSE: GANGAPHARM.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Bharat Brijmohan Sharma
- Employees
- 19
- Headquarters
- Mumbai, India
- IPO year
- 2016
- Market cap
- ₹70.9M
- Website
- https://www.ayurvedganga.com
Loading GANGAPHARM…
Loading profile data…Frequently asked questions about GANGAPHARM
What does Ganga Pharmaceuticals Limited (GANGAPHARM.BO) do?
Ganga Pharmaceuticals Ltd. engages in the manufacturing and trading of pharmaceuticals and allied products. It focuses on manufacturing, marketing, and distribution of Bulk Ayurvedic medicines. Its products include Ampachan Vati, Khadira Vati, and Nirmalaya churna. The firm offers acidity, antidandruff, antioxidants, constipation, dental care, d...
Where does GANGAPHARM.BO trade?
Ganga Pharmaceuticals Limited (GANGAPHARM.BO) trades on the Bombay Stock Exchange.
What sector is GANGAPHARM.BO in?
Ganga Pharmaceuticals Limited (GANGAPHARM.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Ganga Pharmaceuticals Limited?
Bharat Brijmohan Sharma is the chief executive officer of Ganga Pharmaceuticals Limited (GANGAPHARM.BO).
Where is Ganga Pharmaceuticals Limited headquartered?
Ganga Pharmaceuticals Limited is headquartered in India.
Does GANGAPHARM.BO pay a dividend?
Ganga Pharmaceuticals Limited (GANGAPHARM.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GANGAPHARM.BO go public?
Ganga Pharmaceuticals Limited (GANGAPHARM.BO) completed its initial public offering in 2016.